The Mush Room | Episode 6: The Truth About Mushroom Testing with Chris Pauli of Tryptomics

What's actually in your mushroom product? The answer might surprise you, and it's exactly why this conversation matters.

In this episode, Johnny sits down with Chris Pauli, founder of Tryptomics, a psychedelic and cannabis testing laboratory based in Colorado. With deep roots in cannabis pharmacognosy and a vision for personalized natural medicine, Chris is one of the most knowledgeable people working at the intersection of science, fungi, and human health. This is one of the most science-forward episodes of The Mush Room yet, pulling back the curtain on an industry growing faster than regulation can keep up with.

They break down the biggest misconceptions in mushroom testing on both the consumer and manufacturer side, what "active ingredients" really means in a natural product, and how compound classes like triterpenoids, hericinones, and tryptamines each play a distinct role in what you feel and how you heal.

The conversation gets into the entourage effect in mushrooms and why chasing maximum potency may actually be working against the outcome most people want. Healing centers in Colorado are already finding that patients do better on lower-potency whole mushrooms than concentrated high-potency doses, and the science points directly to all the compounds we haven't studied yet.

Johnny and Chris dig into the pharmaceutical race around psilocybin, why the molecule can't be patented, what pro-drugs like 4-ACO-DMT actually are, and the recent report of a 77% success rate treating depression without psychotropic effects. They also cover what Eli Lilly's acquisition of a 5-MeO-DMT nasal spray means for the future of delivery mechanisms.

One of the most important segments covers what Tryptomics found testing smoke shop mushroom chocolates: synthetic tryptamines, prescription drugs, and in most cases, zero actual mushrooms. Chris walks through the Diamond Shrooms recall, how the Amanita ban came about, and how the synthetic tryptamine market is running the same playbook as K2 and Spice.

They cover the state-by-state legalization picture, comparing Oregon and Colorado, and why Illinois passing psilocybin and MDMA access for veterans is a signal that five to ten more states could follow within the year. From there the conversation opens into the chemistry of DMT and ayahuasca, and something more philosophical: is DMT a place you travel to, or a place already inside you?

They close with what's coming from Tryptomics, including an expanded Lion's Mane panel and a long-term vision for personalized mushroom medicine that preserves genetic diversity and builds on what the cannabis industry got wrong.

About Chris Pauli:

Chris Pauli is the founder of Tryptomics, a psychedelic and cannabis testing laboratory in Colorado focused on identifying the full spectrum of bioactive compounds in natural products and pushing mushroom science forward.

Connect with Tryptomics:

Find Tryptomics on Instagram for lab results, compound education, and the latest in mushroom science.

https://forgotten.life/ is live now with mushroom supplements, gummies, and tinctures.

01:06 Introduction to the episode and guest expertise

02:04 Current misconceptions in mushroom testing

03:54 The cost and value of quality mushroom products

05:50 The role of testing in standardizing products

07:40 Active ingredients in medicinal mushrooms

09:44 The science of active compounds and their effects

11:24 Personalized medicine and mushroom strains

13:22 Testing and standardization challenges in natural products

15:27 Pharmaceutical approaches to psychedelics

17:04 Legal developments and legislation updates

19:13 The future of mushroom research and industry